Alpha-Tocotrienol Prevents Oxidative Stress-Mediated Post-Translational Cleavage of Bcl-xL in Primary Hippocampal Neurons.
Adenosine Triphosphate
/ metabolism
Animals
Antioxidants
/ pharmacology
Cells, Cultured
Hippocampus
/ cytology
Membrane Potential, Mitochondrial
Mitochondria
/ drug effects
Neurons
/ drug effects
Neuroprotective Agents
/ pharmacology
Oxidative Stress
Protein Processing, Post-Translational
Proteolysis
Rats
Rats, Sprague-Dawley
Reactive Oxygen Species
/ metabolism
Tocotrienols
/ pharmacology
bcl-X Protein
/ metabolism
Bcl-xL
antioxidant
mitochondria
tocotrienol
∆N-Bcl-xL
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
28 Dec 2019
28 Dec 2019
Historique:
received:
17
05
2019
revised:
24
12
2019
accepted:
25
12
2019
entrez:
8
1
2020
pubmed:
8
1
2020
medline:
12
5
2020
Statut:
epublish
Résumé
B-cell lymphoma-extra large (Bcl-xL) is an anti-apoptotic member of the Bcl2 family of proteins, which supports neurite outgrowth and neurotransmission by improving mitochondrial function. During excitotoxic stimulation, however, Bcl-xL undergoes post-translational cleavage to ∆N-Bcl-xL, and accumulation of ∆N-Bcl-xL causes mitochondrial dysfunction and neuronal death. In this study, we hypothesized that the generation of reactive oxygen species (ROS) during excitotoxicity leads to formation of ∆N-Bcl-xL. We further proposed that the application of an antioxidant with neuroprotective properties such as α-tocotrienol (TCT) will prevent ∆N-Bcl-xL-induced mitochondrial dysfunction via its antioxidant properties. Primary hippocampal neurons were treated with α-TCT, glutamate, or a combination of both. Glutamate challenge significantly increased cytosolic and mitochondrial ROS and ∆N-Bcl-xL levels. ∆N-Bcl-xL accumulation was accompanied by intracellular ATP depletion, loss of mitochondrial membrane potential, and cell death. α-TCT prevented loss of mitochondrial membrane potential in hippocampal neurons overexpressing ∆N-Bcl-xL, suggesting that ∆N-Bcl-xL caused the loss of mitochondrial function under excitotoxic conditions. Our data suggest that production of ROS is an important cause of ∆N-Bcl-xL formation and that preventing ROS production may be an effective strategy to prevent ∆N-Bcl-xL-mediated mitochondrial dysfunction and thus promote neuronal survival.
Identifiants
pubmed: 31905614
pii: ijms21010220
doi: 10.3390/ijms21010220
pmc: PMC6982044
pii:
doi:
Substances chimiques
Antioxidants
0
Bcl2l1 protein, rat
0
Neuroprotective Agents
0
Reactive Oxygen Species
0
Tocotrienols
0
bcl-X Protein
0
Adenosine Triphosphate
8L70Q75FXE
tocotrienol, alpha
B6LXL1832Y
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NINDS NIH HHS
ID : NS045876
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS081746
Pays : United States
Organisme : NINDS NIH HHS
ID : R37 NS045876
Pays : United States
Organisme : University of Alabama
ID : RG14811
Organisme : NINDS NIH HHS
ID : R01 NS112706
Pays : United States
Références
J Mol Biol. 2007 Sep 7;372(1):223-35
pubmed: 17659302
Bioorg Med Chem Lett. 2011 Jun 15;21(12):3693-8
pubmed: 21600768
Trends Cell Biol. 2012 Jun;22(6):318-28
pubmed: 22560661
Cell Res. 2011 Apr;21(4):627-41
pubmed: 21060336
Mol Interv. 2006 Aug;6(4):208-22
pubmed: 16960143
Nat Protoc. 2012 Sep;7(9):1741-54
pubmed: 22936216
Stroke. 2011 Aug;42(8):2308-14
pubmed: 21719775
Immunity. 2003 Sep;19(3):341-52
pubmed: 14499110
J Cell Biol. 2003 Jan 6;160(1):65-75
pubmed: 12515825
J Neurosci. 2002 Jul 1;22(13):5423-31
pubmed: 12097494
J Neurochem. 1984 Nov;43(5):1369-74
pubmed: 6149259
Trends Endocrinol Metab. 2015 Apr;26(4):165-75
pubmed: 25748272
Nat Protoc. 2006;1(5):2406-15
pubmed: 17406484
Free Radic Biol Med. 1991;10(5):263-75
pubmed: 1649783
J Cereb Blood Flow Metab. 1985 Sep;5(3):413-9
pubmed: 4030918
Proc Natl Acad Sci U S A. 2014 Jul 22;111(29):10580-5
pubmed: 24979777
J Physiol. 2007 Dec 15;585(Pt 3):741-58
pubmed: 17947304
Acta Haematol. 2004;111(1-2):42-55
pubmed: 14646344
Electrophoresis. 1997 Dec;18(15):2714-23
pubmed: 9504803
J Neurochem. 2004 Sep;90(6):1281-9
pubmed: 15341512
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
J Cereb Blood Flow Metab. 2011 Nov;31(11):2218-30
pubmed: 21673716
Lipids. 2014 Sep;49(9):855-69
pubmed: 25015768
Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2169-74
pubmed: 18250306
PLoS One. 2011;6(6):e20423
pubmed: 21674052
Cell Death Differ. 2013 Jul;20(7):920-30
pubmed: 23519076
Neural Regen Res. 2017 Nov;12(11):1791-1794
pubmed: 29239317
Science. 1997 Feb 14;275(5302):983-6
pubmed: 9020082
EMBO Rep. 2000 Sep;1(3):266-70
pubmed: 11256610
J Intern Med. 2013 Jun;273(6):602-21
pubmed: 23343471
Methods Enzymol. 1994;234:354-66
pubmed: 7808307
J Neurophysiol. 2008 Mar;99(3):1515-22
pubmed: 18160428
Radiat Res. 2015 Mar;183(3):357-66
pubmed: 25710576
Cell Death Differ. 2009 Aug;16(8):1167-79
pubmed: 19373248
Stroke. 2014 May;45(5):1422-8
pubmed: 24699052
Cell Death Differ. 1999 Jul;6(7):644-51
pubmed: 10453075
Nature. 1996 Feb 8;379(6565):554-6
pubmed: 8596636
Biochemistry. 1993 Oct 12;32(40):10692-9
pubmed: 8399214
J Biol Chem. 2001 Aug 17;276(33):31083-91
pubmed: 11399768
Neuropharmacology. 2004 Nov;47(6):904-15
pubmed: 15527824
Neurosci Lett. 2003 Jan 30;337(1):56-60
pubmed: 12524170
Clin Biochem. 2014 Oct;47(15):116-8
pubmed: 24997420
Cell. 1995 Jan 27;80(2):285-91
pubmed: 7834748
J Biol Chem. 2007 Apr 27;282(17):13123-32
pubmed: 17337444
J Alzheimers Dis. 2015;43(3):927-38
pubmed: 25125472
Stroke. 2005 Oct;36(10):2258-64
pubmed: 16166580
Cell Death Differ. 2017 Nov;24(11):1963-1974
pubmed: 28777375
Biochem J. 2009 Jan 1;417(1):1-13
pubmed: 19061483
J Alzheimers Dis. 2018;64(1):249-267
pubmed: 29889072
J Agric Food Chem. 2003 May 21;51(11):3273-9
pubmed: 12744654
J Alzheimers Dis. 2016 Nov 19;55(2):597-612
pubmed: 27716672
Front Physiol. 2014 Sep 17;5:355
pubmed: 25278904
J Biol Chem. 2009 Jun 26;284(26):17499-511
pubmed: 19293158
J Nutr. 2008 Jun;138(6):1010-8
pubmed: 18492827
J Mol Graph Model. 2018 Jan;79:166-174
pubmed: 29197725
J Neurosci. 2006 Jun 21;26(25):6851-62
pubmed: 16793892
J Neurosci. 2015 Jun 24;35(25):9287-301
pubmed: 26109654
Neurosci Lett. 1995 Aug 11;195(3):179-82
pubmed: 8584204
Pharmacol Res. 2013 Oct;76:17-27
pubmed: 23827162
Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):554-9
pubmed: 9435230
Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4892-7
pubmed: 18347331
Nat Cell Biol. 2013 Jul;15(7):773-85
pubmed: 23792689
Mol Cell. 2015 Apr 16;58(2):199-201
pubmed: 25884366
J Cell Biol. 2011 Oct 17;195(2):263-76
pubmed: 21987637
Nat Cell Biol. 2012 Apr 29;14(6):575-83
pubmed: 22544066
J Biol Chem. 2003 May 9;278(19):17408-20
pubmed: 12611882
Antioxid Redox Signal. 2015 Jan 10;22(2):93-108
pubmed: 24787232
J Neurosci Res. 2008 May 1;86(6):1267-76
pubmed: 18058945
Cell Death Discov. 2016;2:
pubmed: 27239332
Nat Neurosci. 2012 Feb 26;15(4):574-80
pubmed: 22366758
J Biol Chem. 1997 Oct 31;272(44):27886-92
pubmed: 9346936
J Neurosci. 2016 May 18;36(20):5448-61
pubmed: 27194326
Proc Natl Acad Sci U S A. 2004 Sep 14;101(37):13590-5
pubmed: 15342906
J Pharmacol Exp Ther. 2005 Feb;312(2):509-16
pubmed: 15466245
Nat Cell Biol. 2011 Sep 18;13(10):1224-33
pubmed: 21926988
Mol Cell Neurosci. 2004 May;26(1):63-74
pubmed: 15121179
J Alzheimers Dis. 2019;70(s1):S239-S254
pubmed: 30507571
J Biol Chem. 2001 Dec 7;276(49):46326-32
pubmed: 11574549
Oncogene. 1998 Sep 10;17(10):1295-304
pubmed: 9771973